Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Receivables: 2020-2025

Historic Receivables for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $18.0 million.

  • Journey Medical's Receivables rose 68.52% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.9 million, marking a year-over-year increase of 34.07%. This contributed to the annual value of $10.2 million for FY2024, which is 32.79% down from last year.
  • As of Q3 2025, Journey Medical's Receivables stood at $18.0 million, which was up 14.95% from $15.6 million recorded in Q2 2025.
  • Over the past 5 years, Journey Medical's Receivables peaked at $31.7 million during Q3 2021, and registered a low of $8.0 million during Q3 2023.
  • For the 3-year period, Journey Medical's Receivables averaged around $14.6 million, with its median value being $15.2 million (2023).
  • Per our database at Business Quant, Journey Medical's Receivables plummeted by 72.00% in 2023 and then skyrocketed by 83.95% in 2025.
  • Over the past 5 years, Journey Medical's Receivables (Quarterly) stood at $23.1 million in 2021, then climbed by 22.05% to $28.2 million in 2022, then crashed by 46.04% to $15.2 million in 2023, then tumbled by 32.79% to $10.2 million in 2024, then surged by 68.52% to $18.0 million in 2025.
  • Its last three reported values are $18.0 million in Q3 2025, $15.6 million for Q2 2025, and $18.0 million during Q1 2025.